Screener
Oric Pharmaceuticals, Inc. ORIC Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other assets | (679) | (575) |
| Accounts payable and accrued other liabilities | (3,322) | (7,911) |
| Net cash used in operating activities | (32,438) | (32,533) |
| Cash flows from investing activities: | ||
| Acquisitions of property and equipment | (2) | (387) |
| Purchases of investments | (77,973) | (64,663) |
| Maturities of investments | 60,000 | 87,500 |
Item 1. Financial Statements.
FAQ
- What is Oric Pharmaceuticals, Inc.'s operating cash flow?
- Oric Pharmaceuticals, Inc. (ORIC) reported operating cash flow of -$32.44M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s operating cash flow changed year-over-year?
- Oric Pharmaceuticals, Inc.'s operating cash flow increased by 0.3% year-over-year, from -$32.53M to -$32.44M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s operating cash flow has grown at a 16.8% compound annual growth rate (CAGR), from -$59.54M to -$110.97M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Oric Pharmaceuticals, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude